Yuko Shirono, Vladimir Bilim, Tsutomu Anraku, Hiroo Kuroki, Akira Kazama, Masaki Murata, Kaede Hiruma, Yoshihiko Tomita. Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells. Current oncology (Toronto, Ont.). 2023. 30. 6. 5350-5365
Tsutomu Anraku, Hideki Hashidate, Asa Nakahara, Tomoyuki Imai, Yoshiaki Kawakami. Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy. BMC urology. 2023. 23. 1. 38-38
Akira Kazama, Vladimir Bilim, Masayuki Tasaki, Tsutomu Anraku, Hiroo Kuroki, Yuko Shirono, Masaki Murata, Kaede Hiruma, Yoshihiko Tomita. Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma. Scientific reports. 2022. 12. 1. 20386-20386
Tsutomu Anraku, Hideki Hashidate, Asa Nakahara, Tomoyuki Imai, Yoshiaki Kawakami. A 40-year-old man with a rapidly growing intrascrotal tumor in the fibroma-thecoma group. IJU case reports. 2022. 5. 3. 175-178
Akira Kazama, Tsutomu Anraku, Hiroo Kuroki, Yuko Shirono, Masaki Murata, Vladimir Bilim, Andrey Ugolkov, Kazuhide Saito, Yoshihiko Tomita. Development of patient-derived tumor organoids and a drug testing model for renal cell carcinoma. Oncology reports. 2021. 46. 4
